Biote reports second quarter 2023 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the second quarter ended june 30, 2023. second quarter 2023 financial highlights (all financial result comparisons made are against the prior year period) revenue of $49.3 million, a 19.1% increase gross profit margin of 67.9%, a 60-basis point increase net loss of $(13.1) million and gaap loss pe.
BTMD Ratings Summary
BTMD Quant Ranking